CompletedPhase 4

Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy

Egypt90 participantsStarted 2021-03-25

Plain-language summary

The effect of low dose nalbuphine or ketamine in the prevention of emergence agitation after sevoflurane anesthesia in children undergoing tonsillectomy with or without adenoidectomy. This randomized double-blind study was carried out at, Ain shams University Hospitals, from March 2021 to June 2021 on 90 patients after approval of the ethical committee.

Who can participate

Age range4 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 4 - 10 years.
✓. Sex: Both sexes
✓. Patients with ASA classificaion I and II.

Exclusion criteria

✕. Declining to give written informed consent.
✕. History of allergy to the medications used in the study.
✕. psychiatric disorder.
✕. ASA classification III-V.
✕. Fever ,cough , asthma or upper respiratory tract infection .
✕. Anticipated difficult airway .
✕. Hearing defect .
✕. Neurological disorder.

What they're measuring

Emergence Agitation

Timeframe: At Time zero (The time of extubation)

Trial details

NCT IDNCT05176119

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-25

View on ClinicalTrials.gov More Pediatric ALL trials